跳至主要内容
临床试验/NCT01207505
NCT01207505已完成不适用

Emotion Regulation Group Therapy for Bipolar Disorder

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
38
试验地点
2
主要终点
Hamilton Depression Rating Scale

研究概览

简要总结

Psychoeducation has been the only group treatment developed for bipolar disorder thus far. Deficits in emotion regulation, a core impairment among patients with bipolar disorder, are not directly addressed in this treatment. The objective of this study is to develop a group treatment for bipolar disorder that focuses on emotion regulation strategies (Enhancing Emotion Regulation; EER). This study will examine the efficacy of this treatment using an open trial design. It is hypothesized that patients who receive EER will show a reduction in mood symptoms and improvement in well-being. Reductions in emotion regulation difficulties will predict improvements.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of bipolar I disorder.
  • Able to provide written informed consent.
  • Men or women aged 18-
  • Able to read and understand English.
  • Psychiatrist prescribing mood-stabilizing medication.
  • Participates in bimonthly individual psychotherapy

排除标准

  • Subjects with suicidal ideation where outpatient treatment is determined unsafe by the study clinician. These patients will be immediately referred to appropriate clinical treatment.
  • History of seizure disorder, brain injury, any history of known neurological disease (multiple sclerosis, degenerative disease such as ALS, Parkinson disease and any movement disorders, etc).
  • History or current diagnosis of the following Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) psychiatric illness: organic mental disorder, schizophrenia, schizoaffective disorder, delusional disorder, psychotic disorders not otherwise specified, major depressive disorder, patients with mood congruent or mood incongruent psychotic features, patients with substance dependence disorders, including alcohol, active within the last 12 months.
  • Patients who currently meet criteria for a major depressive episode, a manic episode, or a mixed episode. Excluded participants may remain on a waiting list to partake in a future group dependent on mood stabilization.
  • Patients who have had electroconvulsive therapy (ECT) within the 6 months preceding enrollment.

结局指标

主要结局

Hamilton Depression Rating Scale

时间窗: Up to 24 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thilo Deckersbach

Director of Psychology, Bipolar Clinic and Research Program Associate Professor of Psychology, Harvard Medical School

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验